(Q95718298)
Statements
A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 (English)
0 references
1 reference
May 2020
0 references
August 2021
0 references
10,260
0 references
1 reference
5 year
0 references